GLP-1 drives the feeling of fullness, prompts insulin release, slows gastric emptying, and reduces appetite
Estrogens, in turn, have negative feedback effects on the hypothalamic-pituitary-gonadal axis, first lowering gonadotropin-releasing hormone (GnRH), which in turn lowers both gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH) [36]
Best Overall First month $179 then $299/mo 4.8 Best Overall weight-management support from $179 first month Physician review + personalized plan Unlimited messaging with care team No contracts cancel anytime Free shipping to your door 24/7 patient support Visit MEDVi Health screening required
External resources New England Journal of Medicine: Retatrutide Phase 2 Trial Results PubMed Central: Systematic Review of Retatrutide Weight and Metabolic Markers Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Liver Disease For researchers serious about optimizing every aspect of their retatrutide protocol, SeekPeptides provides the most comprehensive resource available
These central effects translate into substantial weight loss - typically 5%-15% of body weight with current GLP-1 RAs - which directly ameliorates hepatic steatosis by reducing adipose tissue mass, reducing hepatic free fatty acid influx, and improving insulin sensitivity
/ 10 Low
